|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03218124 |
|
Date of registration:
|
10/07/2017 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Optimal Remifentanil Concentration and Thyroidectomy
ORCO |
|
Scientific title:
|
Optimal Effect Site Remifentanil Concentration for Smooth Extubation After Thyroid Surgery |
|
Date of first enrolment:
|
October 1, 2017 |
|
Target sample size:
|
30 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03218124 |
|
Study type:
|
Interventional |
|
Study design:
|
Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Italy
| | | | | | | |
|
Contacts
|
|
Name:
|
Paolo Onida, MD |
|
Address:
|
|
|
Telephone:
|
+39 07051096543 |
|
Email:
|
paolo.onida80@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Gabriele Finco, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Cagliari University |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- 18
- 6 hrs fasting
- American society of anesthesiology (ASA) Physical Status I o II
- Informed consent
Exclusion Criteria:
- Absence of inclusion criteria
- Use of cough suppressors, angiotensin converting enzyme-inhibitors, sedatives 4 weeks
before surgery
- Arhythmia, pacemaker or unstable cardiovascular disease
- Hepatic or renal failure
- Anticipated difficulty in airways management
- Chronic obstructive pulmonary disease (COPD), Asthma, increased risk for inhalation,
airway infection in the previous 4 weeks;
- Smoker
- Obesity (BMI >35)
- Pregnancy
- Hypersensitivity to drugs administered for the study
Age minimum:
18 Years
Age maximum:
67 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Anesthesia
|
|
Intervention(s)
|
|
Other: Remifentanil Effect site concentration
|
|
Primary Outcome(s)
|
|
Cough
[Time Frame: 15 minutes after surgery]
|
|
Secondary Outcome(s)
|
|
Hemodynamics 1
[Time Frame: 15 minutes after surgery]
|
|
Hemodynamics 2
[Time Frame: 15 minutes after surgery]
|
|
Respiratory outcome 1
[Time Frame: 15 minutes after surgery]
|
|
Respiratory outcome 2
[Time Frame: 15 minutes after surgery]
|
|
Secondary ID(s)
|
|
Remismooth2217
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|